CAS 1884220-36-3

Formula: C21H21BrN4O5

InChI: InChI=1S/C21H21BrN4O5/c1-23-19(27)13-7-5-6-8-15(13)31-20-14(22)11-24-21(26-20)25-12-9-16(28-2)18(30-4)17(10-12)29-3/h5-11H,1-4H3,(H,23,27)(H,24,25,26)

InChI key: NEXGBSJERNQRSV-UHFFFAOYSA-N

SMILES: CNC(=O)C1=CC=CC=C1OC2=NC(=NC=C2Br)NC3=CC(=C(C(=C3)OC)OC)OC

SBI-0206965

CAS: 1884220-36-3

SBI-0206965

Formula: C₂₁H₂₁BrN₄O₅

Purity: ≥98%

Molecular weight: 489.32

Ref: 54-BUP05708

SBI-0206965

CAS: 1884220-36-3

Formula: C₂₁H₂₁BrN₄O₅

Purity: 95%

Color and Shape: Solid

Molecular weight: 489.3192

Ref: IN-DA00ABP0

SBI-0206965

CAS: 1884220-36-3

SBI-0206965 is a potent, selective and cell-permeable autophagy kinase ULK1 inhibitor with IC50 of 108 nM for ULK1 kinase activity and 711 nM for ULK2.

Formula: C₂₁H₂₁BrN₄O₅

Purity: 99.13%

Color and Shape: White Solid

Molecular weight: 489.32

Ref: TM-T2128

SBI-0206965

CAS: 1884220-36-3

2-((5-Bromo-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)oxy)-N-methylbenzamide

Formula: C₂₁H₂₁BrN₄O₅

Purity: 95%

Molecular weight: 489.32

Ref: IN-DG435581

2-((5-Bromo-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)oxy)-N-methylbenzamide

CAS: 1884220-36-3

Purity: 98%

Molecular weight: 489.326

Ref: 10-F981133

SBI-0206965

CAS: 1884220-36-3

SBI-0206965 is a small molecule that inhibits the transcriptional activity of nuclear DNA. It has been shown to inhibit cellular transformation in humans and animal models. This drug also inhibits the production of proteins and enzymes for cellular growth and proliferation, leading to cell death. SBI-0206965 has been shown to interact with pharmacological agents such as carboplatin and paclitaxel, which are used to treat cancerous cells. The drug is currently being studied as a treatment for bowel disease, skin cancer, and other cancers.

Purity: Min. 95%

Ref: 3D-BS170577